S. Mueller

Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan

J. Huebner, H. Heinzer, M. Baier, 2014, Cancer Microenvironment.

Redirecting and Modulating Rationalizations of Tumor-Immanent Normative Functions in Castration-Resistant Prostate Cancer

J. Huebner, H. Heinzer, M. Baier, 2013 .

IL-2 stromal signatures dissect immunotherapy response groups in non-small cell lung cancer (NSCLC)

N. Matigian, M. Cumberbatch, J. Monkman, 2021, medRxiv.